These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23216106)

  • 1. Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.
    Jover E; Marín F; Roldán V; Montoro-García S; Valdés M; Lip GY
    Ann Med; 2013 May; 45(3):274-90. PubMed ID: 23216106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thromboembolic and bleeding risk assessment in patients with non-rheumatic atrial fibrillation using CHA2DS2-VASc and HAS-BLED scoring systems].
    Bozić I; Cvitković I; Carević V; Caljkusić K; Trgo G; Fabijanić D
    Lijec Vjesn; 2013; 135(3-4):86-91. PubMed ID: 23671975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.
    Glotzer TV; Ziegler PD
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S14-23. PubMed ID: 23790594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of endothelial (dys)function in atrial fibrillation.
    Krishnamoorthy S; Lim SH; Lip GY
    Ann Med; 2009; 41(8):576-90. PubMed ID: 19711210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombotic risk factors and antithrombotic treatment in atrial fibrillation].
    Bounhoure JP
    Bull Acad Natl Med; 2011; 195(4-5):963-74; discussion 974-7. PubMed ID: 22375363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke prevention in atrial fibrillation.
    Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk stratification for thromboembolism and antithrombotic prophylaxis in atrial fibrillation].
    Di Pasquale G; Riva L
    G Ital Cardiol (Rome); 2012 Nov; 13(11 Suppl 1):11S-18S. PubMed ID: 23160015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which patients with atrial fibrillation need anticoagulation?].
    Despotovic SF; Siewe S; Keta A
    Rev Med Suisse; 2010 Sep; 6(264):1816-8, 1820. PubMed ID: 20964018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endothelium and atrial fibrillation. The prothrombotic state revisited.
    Freestone B; Lip GY
    Hamostaseologie; 2008 Oct; 28(4):207-12. PubMed ID: 18836646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants].
    Colonna P; Abrignani MG; Colivicchi F; Verdecchia P; Alunni G; Bongo AS; Ceravolo R; Oliva F; Rakar S; Riccio C; Scherillo M; Valle R; Bovenzi F;
    G Ital Cardiol (Rome); 2013 Apr; 14(4):295-322. PubMed ID: 23567775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Differences of Thromboembolic Events in Atrial Fibrillation.
    Cheng EY; Kong MH
    Am J Cardiol; 2016 Mar; 117(6):1021-7. PubMed ID: 26923085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
    Go AS
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S58-65. PubMed ID: 15152747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.